Structural studies of NaV1.5 and functional implications.
NaV1.5 的结构研究和功能意义。
基本信息
- 批准号:9443872
- 负责人:
- 金额:$ 38.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Voltage-gated Na channels (NaV) initiate electrical impulses in neurons and the heart. Mutations in SCN1A and SCN2A, which encode the neuronal channels NaV1.1 and NaV1.2, respectively, cause inherited epilepsy syndromes. Mutations in SCN5A, which encodes the major subtype of NaV channel in heart (NaV1.5), are linked to many cardiac arrhythmogenic disorders, such as Long QT syndrome (LQTS) and Brugada syndrome (BrS). The main structural components of NaV channels are four homologous repeats, which assemble in a tetrameric configuration within the membrane to control voltage-dependent Na+ conduction, and a cytosolic C-terminal domain (CTD) that serves as a binding site for many auxiliary regulatory proteins and is a hotspot for disease-causing mutations. Among these auxiliary CTD-interacting proteins, the ubiquitous Ca2+ sensor calmodulin (CaM) and fibroblast growth factor homologous factors (FHFs; FGF11-FGF14) are of particular interest: many disease- causing mutations are localized to their putative interaction domains within the CTDs of specific NaV channels; FGF14 is itself a locus for the neurodegenerative disorder spinocerebellar ataxia 27; and Ca2+ regulation of NaV channels by CaM is poorly understood. A lack of structural information for these interactions with the CTD, however, has prevented an understanding of the roles of the CTDs, these auxiliary proteins in channel regulation, and the molecular basis of mutational effects on NaV that lead to disease. Building on recent success in determining the crystal structure of a NaV CTD in complex with CaM and an FHF; and in defining new roles for FHFs in regulation of NaV channel gating and trafficking, we propose to define the mechanisms of NaV channel regulation by Ca2+/CaM, and FHFs and to uncover the molecular basis of the mutational effects on NaV CTDs and their associated proteins that lead to channelopathies. To achieve these goals, we propose the following specific aims: 1. Structure-function studies to determine how Ca2+/CaM regulate NaV channel function, using electrophysiology and biochemistry, to probe insights gained from structural determination; 2. Structure-function studies to determine how FHFs regulate NaV channel function and how FHFs co-operate with CaM for channel regulation; 3. Physiological investigations of the consequences of FHF regulation of NaV1.5. Because NaV channelopathies and mutations in FHFs are associated with neurodegenerative diseases, epilepsy syndromes, and cardiac arrhythmias, the proposed project has great potential to illuminate the molecular basis of multiple channelopathies in multiple organ systems due to NaV CTD mutations and, more generally, to uncover fundamental aspects of NaV channel structure-function.
描述(由申请人提供):电压门控Na通道(NaV)在神经元和心脏中启动电脉冲。分别编码神经元通道NaV1.1和NaV1.2的SCN 1A和SCN 2A的突变导致遗传性癫痫综合征。SCN 5A编码心脏中NaV通道的主要亚型(NaV1.5),其突变与许多心脏致心律失常性疾病有关,如长QT综合征(LQTS)和Brugada综合征(BrS)。NaV通道的主要结构组分是四个同源重复序列,其在膜内组装成四聚体构型以控制电压依赖性Na+传导,以及胞质C末端结构域(CTD),其充当许多辅助调节蛋白的结合位点,并且是致病突变的热点。 在这些辅助CTD相互作用蛋白中,普遍存在的Ca 2+传感器钙调素(CaM)和成纤维细胞生长因子同源因子FHF; FGF 11-FGF 14)是特别感兴趣的:许多致病突变定位于特定NaV通道的CTD内的它们推定的相互作用结构域; FGF 14本身是神经变性病症脊髓小脑共济失调27的基因座; Ca 2+通过CaM对NaV通道的调节还知之甚少。然而,缺乏与CTD的这些相互作用的结构信息,阻碍了对CTD、这些辅助蛋白在通道调节中的作用以及导致疾病的NaV突变效应的分子基础的理解。 基于最近成功确定NaV CTD与CaM和FHF复合物的晶体结构,以及定义FHF在NaV通道门控和运输调节中的新作用,我们建议定义Ca 2 +/CaM和FHF调节NaV通道的机制,并揭示导致通道病的NaV CTD及其相关蛋白突变效应的分子基础。 为实现这些目标,我们提出以下具体目标:1.结构-功能研究,以确定Ca 2 +/CaM如何调节NaV通道功能,使用电生理学和生物化学,以探索从结构测定中获得的见解; 2.结构-功能研究以确定FHF如何调节NaV通道功能以及FHF如何与CaM合作进行通道调节; 3. FHF调节NaV1.5的后果的生理学研究。 由于NaV通道病和FHF突变与神经退行性疾病、癫痫综合征和心律失常相关,因此该项目具有很大的潜力,可以阐明NaV CTD突变导致的多器官系统中多通道病的分子基础,更普遍地说,可以揭示NaV通道结构-功能的基本方面。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Divide, multitask, and conquer: Coordination in channel regulation.
分而治之:渠道监管的协调。
- DOI:10.1080/19336950.2017.1292814
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Pablo,JuanLorenzo;Pitt,GeoffreyS
- 通讯作者:Pitt,GeoffreyS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geoffrey S Pitt其他文献
Geoffrey S Pitt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geoffrey S Pitt', 18)}}的其他基金
Multidisciplinary Research Training in Cardiovascular Disease
心血管疾病多学科研究培训
- 批准号:
10495005 - 财政年份:2022
- 资助金额:
$ 38.7万 - 项目类别:
Multidisciplinary Research Training in Cardiovascular Disease
心血管疾病多学科研究培训
- 批准号:
10656528 - 财政年份:2022
- 资助金额:
$ 38.7万 - 项目类别:
Investigating the role of CaV1.2 in aortic valve stenosis
研究 CaV1.2 在主动脉瓣狭窄中的作用
- 批准号:
10421276 - 财政年份:2020
- 资助金额:
$ 38.7万 - 项目类别:
Investigating the role of CaV1.2 in aortic valve stenosis
研究 CaV1.2 在主动脉瓣狭窄中的作用
- 批准号:
10132390 - 财政年份:2020
- 资助金额:
$ 38.7万 - 项目类别:
Investigating the role of CaV1.2 in aortic valve stenosis
研究 CaV1.2 在主动脉瓣狭窄中的作用
- 批准号:
10611495 - 财政年份:2020
- 资助金额:
$ 38.7万 - 项目类别:
Molecular and circuit defects underlying different SCN2A mutations and ASDs
不同 SCN2A 突变和自闭症谱系障碍 (ASD) 背后的分子和电路缺陷
- 批准号:
10362623 - 财政年份:2019
- 资助金额:
$ 38.7万 - 项目类别:
Molecular and circuit defects underlying different SCN2A mutations and ASDs
不同 SCN2A 突变和自闭症谱系障碍 (ASD) 背后的分子和电路缺陷
- 批准号:
10596085 - 财政年份:2019
- 资助金额:
$ 38.7万 - 项目类别:
Investigation of the roles for CaV1.2 in non-excitable tissue during development
研究 CaV1.2 在发育过程中非兴奋组织中的作用
- 批准号:
9348666 - 财政年份:2016
- 资助金额:
$ 38.7万 - 项目类别:
Investigation of the roles for CaV1.2 in non-excitable tissue during development
研究 CaV1.2 在发育过程中非兴奋组织中的作用
- 批准号:
10011883 - 财政年份:2016
- 资助金额:
$ 38.7万 - 项目类别:
Structural studies of NaV1.5 and functional implications
NaV1.5 的结构研究和功能意义
- 批准号:
8685317 - 财政年份:2013
- 资助金额:
$ 38.7万 - 项目类别:
相似国自然基金
脂滴聚集型小胶质细胞介导的髓鞘病变促进小鼠抑郁样行为及其机制研究
- 批准号:82371528
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
星形胶质细胞介导的髓鞘吞噬参与慢性脑低灌注白质损伤的机制研究
- 批准号:82371307
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
REU Site: Field and laboratory studies of coastal marine processes at the Shannon Point Marine Center
REU 站点:香农角海洋中心沿海海洋过程的现场和实验室研究
- 批准号:
2349136 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Continuing Grant
CAS: Optimization of CO2 to Methanol Production through Rapid Nanoparticle Synthesis Utilizing MOF Thin Films and Mechanistic Studies.
CAS:利用 MOF 薄膜和机理研究,通过快速纳米粒子合成优化 CO2 生产甲醇。
- 批准号:
2349338 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Continuing Grant
CAREER: Statistical Power Analysis and Optimal Sample Size Planning for Longitudinal Studies in STEM Education
职业:STEM 教育纵向研究的统计功效分析和最佳样本量规划
- 批准号:
2339353 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Continuing Grant
Experimental and numerical studies on internal erosion of granular soils
颗粒土内部侵蚀的实验与数值研究
- 批准号:
DE240101106 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Discovery Early Career Researcher Award
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Cryo-EM studies of a metazoan replisome captured ex vivo during elongation and termination
在延伸和终止过程中离体捕获的后生动物复制体的冷冻电镜研究
- 批准号:
BB/Y006232/1 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Research Grant
Cryo-EM studies of a metazoan replisome captured ex vivo during elongation and termination
在延伸和终止过程中离体捕获的后生动物复制体的冷冻电镜研究
- 批准号:
BB/Y006151/1 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Research Grant
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 38.7万 - 项目类别:














{{item.name}}会员




